Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Baird raises HB Fuller shares price target on margin growth

EditorIsmeta Mujdragic
Published 04/01/2024, 07:19 AM

On Monday, Baird has adjusted its price target for HB Fuller (NYSE:FUL), a company specializing in adhesives, sealants, and other specialty chemical products, from $80.00 to $90.00. The firm has maintained a Neutral rating on the stock. The revision reflects the analyst's recognition of the company's significant margin expansion across its portfolio. The analyst believes that while HB Fuller has demonstrated impressive margin growth, increasing sales volumes are essential for sustaining these margins.

The company has faced a mixed fundamental backdrop, as evidenced by recent challenges in Europe during the first fiscal quarter of 2024, which were somewhat balanced by growing strength in the Chinese market. Despite these mixed signals, the analyst cites the company's premium valuation and the decision to maintain a Neutral stance.

The new price target of $90.00 is based on approximately 20 times the firm's forecasted earnings per share (EPS) for the fiscal year 2025, which is estimated at $4.65. This adjustment indicates Baird's expectation of HB Fuller's continued financial performance and the potential for the company's stock value.

The report follows HB Fuller's ongoing efforts to expand margins amidst a complex global economic environment, with particular attention to the company's operations in Europe and China. The updated price target suggests that Baird sees a stable outlook for HB Fuller, with the current valuation reflecting the company's earnings prospects.

InvestingPro Insights

As HB Fuller (NYSE:FUL) navigates a dynamic market landscape, real-time data and insights from InvestingPro offer a clearer picture of the company's financial standing. With a market capitalization of $4.35 billion and a P/E ratio that has adjusted to a more favorable 24.83 in the last twelve months as of Q1 2024, HB Fuller shows signs of a robust valuation. This is further substantiated by a strong free cash flow yield, as highlighted by one of the InvestingPro Tips, indicating that the company is generating healthy cash flows relative to its share price.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Another notable InvestingPro Tip is the company's impressive track record of maintaining dividend payments for 54 consecutive years, which signals a commitment to shareholder returns. This is particularly relevant for investors seeking stable income streams through dividends. Moreover, the company's operating income margin of 11.79% in the last twelve months as of Q1 2024 showcases its ability to manage expenses and convert revenue into operating income efficiently.

For readers interested in further insights, there are more InvestingPro Tips available for HB Fuller at https://www.investing.com/pro/FUL. To deepen your investment research, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro, where you can access a comprehensive list of additional tips to inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.